Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trial

Summary: Background: Depression is three to four times more prevalent in patients with neurological and inflammatory disorders than in the general population. For example, in patients with multiple sclerosis, the 12-month prevalence of major depressive disorder is around 25% and it is associated wi...

Full description

Bibliographic Details
Main Authors: Stefan M Gold, ProfPhD, Tim Friede, ProfPhD, Björn Meyer, PhD, Rona Moss-Morris, ProfPhD, Joanna Hudson, PhD, Susanna Asseyer, MD, Judith Bellmann-Strobl, MD, Andreas Leisdon, MSc, Leonie Ißels, MSc, Kristin Ritter, MSc, David Schymainski, MSc, Hayley Pomeroy, BSc, Sharon G Lynch, ProfMD, Julia S Cozart, MA, Joan Thelen, PhD, Cristina A F Román, PhD, Margaret Cadden, PhD, Erin Guty, PhD, Stephanie Lau, MSc, Jana Pöttgen, PhD, Caren Ramien, PhD, Susan Seddiq-Zai, MSc, Anna-Maria Kloidt, MSc, Johannes Wieditz, PhD, Iris-Katharina Penner, ProfPhD, Friedemann Paul, ProfMD, Nancy L Sicotte, ProfMD, Jared M Bruce, ProfPhD, Peter A Arnett, ProfPhD, Christoph Heesen, ProfMD
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:The Lancet: Digital Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2589750023001097